This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a trifluoromethyl group and an imidazopyridine core, makes it a valuable intermediate for designing molecules with potential therapeutic properties. It is often explored in the development of small-molecule inhibitors targeting specific enzymes or receptors, particularly in areas like oncology, inflammation, and central nervous system disorders. The trifluoromethyl group enhances the compound's metabolic stability and binding affinity, making it a key component in optimizing drug efficacy and pharmacokinetics. Additionally, it may be used in the study of fluorescence properties due to its unique chemical structure, aiding in the development of imaging agents or probes for biological research.